Cue Biopharma’s immunotherapies are the first-ever class of therapeutics in development for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system.
Our biologics address the specificity and diversity of the human immune system to cure disease by activating tumor-specific T cells directly in the patient’s body to attack only cancer cells. They have the potential to provide the patient with a more effective response while preserving safety, by restoring the capacity of a patient’s own immune system to fight cancer.
